Provides AI-driven data analytics and genomic testing designed to support precision medicine, particularly in oncology. The company aggregates clinical, molecular, and imaging data to help physicians guide treatment decisions while supplying pharmaceutical firms with datasets used in drug developmen...
2 members of Congress have disclosed 3 trades in Tempus AI, Inc. (TEM), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-01-16 | Nancy Pelosi | buy | $50K – $100K |
| 2025-05-09 | Rob Bresnahan | buy | $1K – $15K |
| 2025-01-14 | Nancy Pelosi | buy | $50K – $100K |